Macrogenics (MGNX) Current Assets (2012 - 2026)
Macrogenics' (MGNX) quarterly Current Assets came in at $182.5 million in Q1 2026, little changed year-on-year from $182.1 million in Q1 2025, and down 17.01% on a QoQ basis from $219.9 million in Q4 2025.
Macrogenics (MGNX) Current Assets (2012 - 2026) Analysis & Trends
Macrogenics (MGNX) has 15 years of Current Assets data on file, last reported at $182.5 million in Q1 2026.
- On a quarterly basis, Current Assets changed 0.24% year-over-year to $182.5 million in Q1 2026; TTM through Mar 2026 was $182.5 million, a 0.24% change from a year earlier, with the FY2025 full-year figure at $219.9 million, up 1.13% from the prior year.
- Current Assets for Q1 2026 stood at $182.5 million, down from $219.9 million in the prior quarter.
- Over the last five years, Current Assets for MGNX reached as high as $291.3 million in Q3 2023 and fell as low as $147.8 million in Q3 2022.
- Historically, Current Assets has averaged $215.5 million across 5 years, with a median of $218.2 million in 2022.
- Across the five-year window, Current Assets slumped 55.84% in 2022 and jumped 97.09% in 2023, its largest moves.
- Year by year, Current Assets stood at $222.2 million in 2022, then advanced by 13.12% to $251.3 million in 2023, then dropped by 13.47% to $217.5 million in 2024, then advanced by 1.13% to $219.9 million in 2025, then declined by 17.01% to $182.5 million in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $182.5 million in Q1 2026, $219.9 million in Q4 2025, and $232.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Macrogenics | 254.43 Mn | 187.92 Mn | - | 182.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 182.52 Mn |
| Dec 31, 2025 | 219.94 Mn |
| Sep 30, 2025 | 232.09 Mn |
| Jun 30, 2025 | 204.95 Mn |
| Mar 31, 2025 | 182.09 Mn |
| Dec 31, 2024 | 217.49 Mn |
| Sep 30, 2024 | 222.20 Mn |
| Jun 30, 2024 | 156.95 Mn |
| Mar 31, 2024 | 202.58 Mn |
| Dec 31, 2023 | 251.34 Mn |
| Sep 30, 2023 | 291.32 Mn |
| Jun 30, 2023 | 254.68 Mn |
| Mar 31, 2023 | 288.94 Mn |
| Dec 31, 2022 | 222.18 Mn |
| Sep 30, 2022 | 147.81 Mn |
| Jun 30, 2022 | 167.63 Mn |
| Mar 31, 2022 | 218.20 Mn |
| Dec 31, 2021 | 279.56 Mn |
| Sep 30, 2021 | 334.70 Mn |
| Jun 30, 2021 | 367.00 Mn |